HR 1432 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To prohibit any Federal law from making the manufacturer of a COVID-19 vaccine immune from suit or liability, or limiting the liability of such a manufacturer, with respect to claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a COVID-19 vaccine, and for other purposes.
Summary
This bill prohibits any federal law from providing immunity or limiting liability for COVID-19 vaccine manufacturers with respect to claims for harm caused by vaccine administration or use. It specifically targets provisions of the Public Health Service Act that currently provide such protections. The bill does not prevent individuals from seeking compensation through existing federal compensation programs for vaccine injuries, nor does it prevent individuals who received compensation through those programs from also bringing civil actions against manufacturers. The prohibition applies retroactively to vaccines administered before or after the bill's enactment. The bill applies to all vaccines licensed or authorized by the FDA to prevent, mitigate, or reduce harm from COVID-19.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Rep. Roy, Chip [R-TX-21] (R-TX)
11 cosponsors
- Rep. Brecheen, Josh [R-OK-2] (R-OK)
- Rep. Cloud, Michael [R-TX-27] (R-TX)
- Rep. Crane, Elijah [R-AZ-2] (R-AZ)
- Rep. Davidson, Warren [R-OH-8] (R-OH)
- Rep. Fulcher, Russ [R-ID-1] (R-ID)
- Rep. Gosar, Paul A. [R-AZ-9] (R-AZ)
- Rep. Harris, Andy [R-MD-1] (R-MD)
- Rep. Higgins, Clay [R-LA-3] (R-LA)
- Rep. Massie, Thomas [R-KY-4] (R-KY)
- Rep. Norman, Ralph [R-SC-5] (R-SC)
- Rep. Perry, Scott [R-PA-10] (R-PA)
Money behind the sponsor
Top reported contributors to Chip Roy’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $112,464
- SBG $13,200
- HUFFINES COMMUNITIES $10,250
- Q2 BANKING $9,900
- WOODFOREST FINANCIAL GROUP $8,700
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Chip Roy → · Outside spending →
Actions (2)
- Feb 18, 2025 Referred to the House Committee on the Judiciary. · house
- Feb 18, 2025 Introduced in House
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
February 18, 2025
Mr. Roy (for himself, Mr. Massie, Mr. Brecheen, Mr. Cloud, Mr. Higgins of Louisiana, Mr. Crane, Mr. Gosar, and Mr. Perry) introduced the following bill; which was referred to the Committee on the Judiciary
A BILL
To prohibit any Federal law from making the manufacturer of a COVID-19 vaccine immune from suit or liability, or limiting the liability of such a manufacturer, with respect to claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a COVID-19 vaccine, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Let Injured Americans Be Legally Empowered Act” or the “LIABLE Act”.
SEC. 2. NO FEDERAL IMMUNITY FROM, OR LIMITATION ON, LIABILITY FOR MANUFACTURERS FOR LOSS CAUSED BY A COVID-19 VACCINE.
(a) In General.—No Federal law, including sections 319F-3, 2111, and 2122 of the Public Health Service Act (42 U.S.C. 247d-6d, 300aa-11, 300aa-22), may make the manufacturer of a COVID-19 vaccine immune from suit or liability, or limit the liability of such a manufacturer, with respect to claims for loss caused by, arising out of, relating to, or resulting from the administration to or the use by an individual of a COVID-19 vaccine.
(b) Rule of Construction.—Nothing in this Act shall be construed to prohibit an individual from seeking compensation through the Countermeasures Injury Compensation Program under section 319F-4 of the Public Health Service Act (42 U.S.C. 247d-6e) or the National Vaccine Injury Compensation Program under subtitle 2 of title XXI of such Act (42 U.S.C. 300aa-10 et seq.).
(c) Relation to Other Programs.—An individual shall not be precluded from bringing a civil action for claims described in subsection (a) on the basis of such individual having sought or received compensation through the Countermeasures Injury Compensation Program under section 319F-4 of the Public Health Service Act (42 U.S.C. 247d-6e) or the National Vaccine Injury Compensation Program under subtitle 2 of title XXI of such Act (42 U.S.C. 300aa-10 et seq.).
(d) Definition.—The term “COVID-19 vaccine” means a vaccine licensed or otherwise authorized by the Food and Drug Administration to prevent, mitigate, or limit—
(1) the harm from COVID-19; or
(2) the transmission of SARS-CoV-2 or a virus mutating therefrom.
(e) Retroactive Applicability.—This Act applies without regard to whether the adminstration or use of a COVID-19 vaccine occurs before, on, or after the date of enactment of this Act. <all>
Comments